ERNA vs LLY · P/E 0.0, rev $582.0K vs P/E 39, rev $65.18B
Eterna Therapeutics Inc (ERNA) versus Eli Lilly and Company (LLY) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Eli Lilly and Company (LLY) is a drug manufacturers - general company listed on NYSE. It is led by David Ricks.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported LLY revenue for 2025-12-31 was $65.18B. Net income was $20.64B. Revenue was up 44.7% from 2024-12-31 to 2025-12-31. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. LLY currently screens at market cap $991.62B and trailing P/E 39.5.
Not investment advice. Open the ERNA and LLY stock pages for the full models.
Not investment advice.